迷走神经切断术与帕金森病:瑞典登记匹配队列研究
基于瑞典全国登记数据,匹配队列研究分析9,430例迷走神经切断术患者与377,200名参照个体,随访7.3百万人年发现4,930例新发帕金森病。总体迷走神经切断术与帕金森病风险无关(HR 0.96,95%CI 0.78-1.17),但干性迷走神经切断术提示风险降低(HR 0.78,95%CI 0.55-1.09),尤其术前至少5年者(HR 0.59,95%CI 0.37-0.93),选择性切断术无关联。
要点
- 总体迷走神经切断术未显著改变帕金森病风险。
- 干性迷走神经切断术可能降低帕金森病风险,尤其提前至少5年。
- 选择性迷走神经切断术与帕金森病风险无关。
核心结论
- 总体迷走神经切断术与帕金森病风险无关,但干性切断术提示潜在保护作用,选择性切断术无关联。
研究设计与样本
- 瑞典全国登记匹配队列研究,纳入1970-2010年9,430例迷走神经切断术患者(干性3,445例,选择性5,978例)和377,200名参照个体,按性别和出生年40:1匹配。
主要发现
- 随访7.3百万人年共识别4,930例新发帕金森病。
- 迷走神经切断术患者帕金森病发病率为61.8/10万人年(干性80.4,选择性55.1),参照个体为67.5/10万人年。
- 总体迷走神经切断术与帕金森病风险无关(HR 0.96,95%CI 0.78-1.17)。
- 干性迷走神经切断术提示风险降低(HR 0.78,95%CI 0.55-1.09),术前至少5年者HR 0.59(95%CI 0.37-0.93)。
- 选择性迷走神经切断术在任何分析中均与帕金森病风险无关。
关键数值与推荐
- 干性迷走神经切断术与帕金森病风险HR 0.78(95%CI 0.55-1.09)。
- 干性迷走神经切断术至少5年前与帕金森病风险HR 0.59(95%CI 0.37-0.93)。
- 总体迷走神经切断术与帕金森病风险HR 0.96(95%CI 0.78-1.17)。
临床怎么用
- 干性迷走神经切断术病史可能提示帕金森病风险降低,尤其术后至少5年,但证据仅为提示性,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine whether vagotomy decreases the risk of Parkinson disease (PD). METHODS: Using data from nationwide Swedish registers, we conducted a matched-cohort study of 9,430 vagotomized patients (3,445 truncal and 5,978 selective) identified between 1970 and 2010 and 377,200 reference individuals from the general population individually matched to vagotomized patients by sex and year of birth with a 40:1 ratio. Participants were followed up from the date of vagotomy until PD diagnosis, death, emigration out of Sweden, or December 31, 2010, whichever occurred first. Vagotomy and PD were identified from the Swedish Patient Register. We estimated hazard ratios (HRs) with 95% confidence intervals (CIs) using Cox models stratified by matching variables, adjusting for country of birth, chronic obstructive pulmonary disease, diabetes mellitus, vascular diseases, rheumatologic disease, osteoarthritis, and comorbidity index. RESULTS: A total of 4,930 cases of incident PD were identified during 7.3 million person-years of follow-up. PD incidence (per 100,000 person-years) was 61.8 among vagotomized patients (80.4 for truncal and 55.1 for selective) and 67.5 among reference individuals. Overall, vagotomy was not associated with PD risk (HR 0.96, 95% CI 0.78-1.17). However, there was a suggestion of lower risk among patients with truncal vagotomy (HR 0.78, 95% CI 0.55-1.09), which may be driven by truncal vagotomy at least 5 years before PD diagnosis (HR 0.59, 95% CI 0.37-0.93). Selective vagotomy was not related to PD risk in any analyses. CONCLUSIONS: Although overall vagotomy was not associated the risk of PD, we found suggestive evidence for a potential protective effect of truncal, but not selective, vagotomy against PD development.
引用
- Liu B, Fang F, Pedersen NL, et al. Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study. Neurology. 2017. PMID: 28446653. doi:10.1212/WNL.0000000000003961
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。